Overview

Adductor Canal Block in Total Knee Arthroplasty

Status:
Not yet recruiting

Trial end date:
2024-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate whether adding ketamine to bupivacaine is superior to bupivacaine alone in terms of providing better pain control for 48 hours postoperatively after TKA.

Phase:

Phase 4

Details

Lead Sponsor:

Assiut University

Treatments:

Bupivacaine
Ketamine